Drugs / [11C] desmethyl-loperamide
[11C] desmethyl-loperamide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01668147 | Aug 2012 → Jun 2016 | drug-induced mental disorder | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C] desmethyl-loperamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01668147 ↗ |
| Modality | Diagnostic / imaging agent | “tracer 11C-desmethylloperamide, a substrate for brain P-glycoprotein, and positron emission tomography (PET)” NCT01668147 ↗ |
| Route | Intravenous | “IV administration of 10-14 mCi of \[11C\] desmethyl-loperamide with PET/CT imaging” NCT01668147 ↗ |